专利检索 ap:("SMITHKLINE BEECHAM LABORATOIRES PHARMACEUTIQUES") AND inv:"FOREST,Marie-Cl. SmithKline Beecham Lab.Pharm." 第 1 页

1.

发明公开
PHARMACEUTICAL COMPOSITION CONTAINING A CLASS III ANTIARRHYTHMIC AGENT AND A CLASS IV ANTIARRHYTHMIC AGENT 失效
标题翻译：药物组合物的III类抗心律不齐药和类抗心律失常药IV CONTAINS

公开(公告)号：EP0752859A1

公开(公告)日：1997-01-15

申请号：EP95914321.0

申请日：1995-03-28

申请人： SMITHKLINE BEECHAM LABORATOIRES PHARMACEUTIQUES

发明人： BRIL, SmithKline Beecham Lab.Pharm. , FAIVRE,SmithKline Beecham Lab.Pharm. , GOUT,B.E.J. SmithKline Beecham Lab. Pharm. , FOREST,Marie-Cl. SmithKline Beecham Lab.Pharm.

IPC分类号： A61K45 , A61K31 , A61P9

CPC分类号： A61K31/275 , A61K31/44 , A61K31/445 , A61K31/18 , A61K2300/00

摘要： A pharmaceutical composition, which composition comprises a class III antiarrhythmic agent and a class IV antiarrhythmic agent, providing that the composition is not a combination of 10νg/kg E4031 and 0.1mg/kg verapamil, and optionally a pharmaceutically acceptable carrier therefor and in particular a pharmaceutical composition which composition comprises a class III and a class IV antiarrhythmic agent, characterised in that the class III reagent is present in an antiarrhythmic effective amount and the class IV antiarrhythmic agent is present in an amount lower than that which provides a substantial calcium blocking effect, and optionally a pharmaceutically acceptable carrier therefor; a process and medical use for such a composition.